tiprankstipranks
Nasus Pharma Ltd. (NSRX)
:NSRX
US Market
NSRX
Nasus Pharma Ltd.
RESEARCH TOOLSreports

Nasus Pharma Ltd. (NSRX) Stock News & Sentiment

11 Followers
Nasus Pharma Moves Intranasal Epinephrine Toward Pivotal Trial After Positive Phase 2 Results
Premium
Company Announcements
Nasus Pharma Moves Intranasal Epinephrine Toward Pivotal Trial After Positive Phase 2 Results
15d ago
6K
NSRX
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
Premium
TipRanks Newswire
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
21d ago
SER
NSRX
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
Premium
TipRanks Newswire
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
24d ago
CTMX
NSRX
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
Premium
Company Announcements
Nasus Pharma’s NS002 Outperforms EpiPen in Phase 2 Anaphylaxis Study, Pivotal Trial Planned for Late 2026
24d ago
6K
NSRX
Nasus Pharma Shareholders Approve Capital Increase and Amended Articles at March 5 Meeting
Premium
Company Announcements
Nasus Pharma Shareholders Approve Capital Increase and Amended Articles at March 5 Meeting
1M ago
6K
NSRX
Nasus Pharma Moves March 5 Shareholder Meeting to Virtual-Only Format Amid Israel Security Situation
Premium
Company Announcements
Nasus Pharma Moves March 5 Shareholder Meeting to Virtual-Only Format Amid Israel Security Situation
1M ago
6K
NSRX
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
Premium
TipRanks Newswire
Nasus Approaches Key Data Readout That Could Reshape the Multi Billion Dollar Epinephrine Market (NYSE: NSRX)
1M ago
NSRX
XERS
More NSRX News >

NSRX News on the Web

Nasus Pharma’s CEO Makes Bold Move With Fresh Insider Buy
TipRanks News
Neutral
Nasus Pharma price target lowered to $18 from $19 at Citizens
TipRanks News
Bullish
Nasus Pharma Moves Intranasal Epinephrine Toward Pivotal Trial After Positive Phase 2 Results
TipRanks News
Bullish
Nasus Pharma advances NS002 to pivotal study following Phase 2 results
TipRanks News
Bullish
Nasus Pharma's NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
GuruFocus News
Bullish
Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)
TipRanks News
Bullish
Nasus Pharma's Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder ...
GuruFocus News
Bullish
Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NSRX’s Media Buzz Sentiment?
Currently, no data Available
What is NSRX’s weekly average amount of articles?
Currently, no data Available
What is NSRX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NBIXNeurocrine
STAAStaar Surgical
AORTArtivion
OWLTOwlet
HUMHumana
Showing the stocks with the most bullish news sentiment over the past week